Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Molecular, Neural, and Cognitive Mechanisms of…

U.S. National Institutes of Health·United States of America

Molecular, Neural, and Cognitive Mechanisms of Non-Invasive Brain Stimulation to Treat Substance Use Disorders

Closes 4/28/2026$500k – $1MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institute on Drug Abuse (NIDA) is seeking to fund research on the molecular, neural, and cognitive mechanisms of non-invasive brain stimulation to treat substance use disorders. The goal is to encourage basic research using animal and human models to elucidate the mechanisms of action of non-invasive brain stimulation techniques such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and transcranial focused ultrasound (tFUS). The research should focus on identifying molecular mechanisms and pathways by which these techniques produce their therapeutic effects in substance use disorders. • The research should use animal models to study the effects of non-invasive brain stimulation on substance use disorders. • The research should investigate the molecular, cellular, and circuit level changes induced by non-invasive brain stimulation protocols. • The research should identify novel clinical targets for non-invasive brain stimulation. • The research should investigate substance use disorder-relevant neurobiological, cognitive, and behavioral responses to non-invasive brain stimulation.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Subramaniam Ananthan(Program Contact)

[email protected]

(301) 435-2199

Key dates

Opened
5/28/2025
Closes
4/28/2026
Projected award
4/1/2027
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
FOR-DA-27-005

Budget estimate

$500,000 – $1,000,000

The estimated funding for this opportunity is $3,000,000, and it is expected to support 4 awards. The budget amount for each award is likely to be around $750,000. However, this amount may vary depending on the scope and complexity of the proposed research project. Factors that may influence the likely payment range include the number of personnel involved, the duration of the project, and the amount of resources required.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 75%

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/12/2021

U.S. National Institutes of Health·United States of America

74% match

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

73% match

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/12/2021

U.S. National Institutes of Health·United States of America

72% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

72% match

Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 1/6/2023

U.S. National Institutes of Health·United States of America

72% match

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Closes 11/8/2027Opened 5/22/2025

U.S. National Institutes of Health·United States of America

72% match

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

Closes 10/25/2027Opened 1/15/2025

U.S. National Institutes of Health·United States of America

72% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

72% match

BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research

Closes 6/9/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

72% match

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 6/16/2023

U.S. National Institutes of Health·United States of America

72% match

Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 9/11/2025

U.S. National Institutes of Health·United States of America

71% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

71% match

Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)

Closes 3/5/2027Opened 9/29/2025

U.S. National Institutes of Health·United States of America

71% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

71% match

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

70% match

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

Closes 10/25/2027Opened 1/15/2025

U.S. National Institutes of Health·United States of America

70% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

70% match

Establishing a Research Network to Guide Foundational Research on Human Consciousness

Closes 2/7/2027Opened 4/28/2026

U.S. National Institutes of Health·United States of America

70% match

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

Closes 6/15/2027Opened 10/23/2024

U.S. National Institutes of Health·United States of America

70% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

70% match

Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)

Closes 1/7/2028Opened 1/13/2023

U.S. National Institutes of Health·United States of America

69% match

NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science

Closes 5/25/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

69% match

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Closes 6/23/2028Opened 8/28/2025

U.S. National Institutes of Health·United States of America

69% match

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 8/13/2024

U.S. National Science Foundation·United States of America

69% match

Cognitive Neuroscience (CogNeuro)

Closes 2/1/2027Opened 10/12/2023